EVENTS

Upcoming Events

There are no upcoming events at this time.

PAST EVENTS

May 24, 2022
Virpax Pharma Virtual Presentation at the H.C. Wainwright Global Investment Conference
Date: Tuesday, May 24th through Friday, May 27th
Time: On Demand starting at 7:00 a.m. ET
Jan 10, 2022
Virpax Pharma Presentation at the H.C. Wainwright BioConnect Virtual Conference
Date: Monday, January 10th through Thursday, January 13th
Time: On Demand from 7:00 a.m. ET to 7:00 p.m.ET daily
Nov 17, 2021
PharmaVOICE Woman of the Week: Sheila Mathias, Ph.D.
Chief Scientific Officer
Virpax Pharmaceuticals
November 17, 2021

Dr. Sheila Mathias, Chief Scientific Officer of Virpax Pharmaceuticals, has an extensive set of complimentary skills that have her positioned perfectly to lead the biotech company to its next phase of success.
Sep 9, 2021
PAINWeek 2021 - Enkephalin as a Potential Analgesic and CNS Modulator
The following poster from Virpax will be presented on Thursday, September 9th from 6:30 p.m. – 8:30 p.m. PST:
Title: Enkephalin as a Potential Analgesic and CNS Modulator
Presenter: Jeffrey A. Gudin, MD, EVP, Chief Medical Officer of Virpax Pharmaceuticals
Abstract ID: 1090715 Poster No. :29
Aug 6, 2019
Virpax Pharmaceuticals to Present at the 2019 Military Health System Research Symposium

BUSINESS INQUIRIES

Virpax Pharmaceuticals, Inc.
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
610.727.4597
info@virpaxpharma.com

INVESTOR INQUIRIES

Betsy Brod
Affinity Growth Advisors
betsy.brod@affinitygrowth.com

MEDIA INQUIRIES

Public Relations
Virpax Pharmaceuticals, Inc.
pr@virpaxpharma.com